cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions

Cairns RA, Harris IS, Mak TW . Regulation of cancer cell metabolism. Nat Rev Cancer 2011; 11:85–95.

DeBerardinis RJ, Cheng T . Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 2010; 29:313–324.

Shaw RJ . Glucose metabolism and cancer. Curr Opin Cell Biol 2006; 18:598–608.

Warburg O . On the origin of cancer cells. Science 1956; 123:309–314.

Soga T . Cancer metabolism: key players in metabolic reprogramming. Cancer Sci 2013; 104:275–281.

Shanware NP, Mullen AR, DeBerardinis RJ, Abraham RT . Glutamine: pleiotropic roles in tumor growth and stress resistance. J Mol Med 2011; 89:229–236.

Le A, Lane AN, Hamaker M, et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab 2012; 15:110–121.

Metallo CM, Gameiro PA, Bell EL, et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 2012; 481:380–384.

Jain M, Nilsson R, Sharma S, et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 2012; 336:1040–1044.

Kalhan SC, Hanson RW . Resurgence of serine: an often neglected but indispensable amino acid. J Biol Chem 2012; 287:19786–19791.

de Koning TJ, Snell K, Duran M, Berger R, Poll-The BT, Surtees R . L-serine in disease and development. Biochem J 2003; 371:653–661.

Tabatabaie L, Klomp LW, Berger R, de Koning TJ . L-serine synthesis in the central nervous system: a review on serine deficiency disorders. Mol Genet Metab 2010; 99:256–262.

Amelio I, Cutruzzolá F, Antonov A, Agostini M, Melino G . Serine and glycine metabolism in cancer. Trends Biochem Sci 2014; 39:191–198.

Locasale JW . Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer 2013; 13:572–583.

Tedeschi PM, Markert EK, Gounder M, et al. Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells. Cell Death Dis 2013; 4:e877.

Vazquez A, Tedeschi PM, Bertino JR . Overexpression of the mitochondrial folate and glycine-serine pathway: a new determinant of methotrexate selectivity in tumors. Cancer Res 2012; 73:478–482.

Lund K, Merrill DK, Guynn RW . The reactions of the phosphorylated pathway of L-serine biosynthesis: thermodynamic relationships in rabbit liver in vivo. Arch Biochem Biophys 1985; 237:186–196.

Anderson DD, Stover PJ . SHMT1 and SHMT2 are functionally redundant in nuclear de novo thymidylate biosynthesis. PLoS One 2009; 4:e5839.

MacFarlane AJ, Liu X, Perry CA, et al. Cytoplasmic serine hydroxymethyltransferase regulates the metabolic partitioning of methylenetetrahydrofolate but is not essential in mice. J Biol Chem 2008; 283:25846–25853.

Amores-Sanchez MI, Medina MA . Glutamine, as a precursor of glutathione, and oxidative stress. Mol Genet Metab 1999; 67:100–105.

Anderson ME . Glutathione: an overview of biosynthesis and modulation. Chem Biol Interact 1998; 111-112:1–14.

Townsend DM, Tew KD, Tapiero H . The importance of glutathione in human disease. Biomed Pharmacother 2003; 57:145–155.

Circu ML, Aw TY . Reactive oxygen species, cellular redox systems, and apoptosis. Free Radical Bio Med 2010; 48:749–762.

Anderson DD, Woeller CF, Chiang EP, Shane B, Stover PJ . Serine hydroxymethyltransferase anchors de novo thymidylate synthesis pathway to nuclear lamina for DNA synthesis. J Biol Chem 2012; 287:7051–7062.

Maddocks OD, Berkers CR, Mason SM, et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 2013; 493:542–546.

Tavana O, Gu W . The hunger games: p53 regulates metabolism upon serine starvation. Cell Metab 2013; 17:159–161.

Amelio I, Markert EK, Rufini A, et al. p73 regulates serine biosynthesis in cancer. Oncogene 2014; 33:5039–5046.

Ding J, Li T, Wang X, et al. The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation. Cell Metab 2013; 18:896–907.

Ye J, Fan J, Venneti S, et al. Serine catabolism regulates mitochondrial redox control during hypoxia. Cancer Discov 2014; 4:1406–1417.

Ma L, Tao Y, Duran A, et al. Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis. Cell 2013; 152:599–611.

Ye J, Mancuso A, Tong X, et al. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci USA 2012; 109:6904–6909.

Brooks TA, Hurley LH . The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics. Nat Rev Cancer 2010; 9:949.

Dang CV . MYC on the path to cancer. Cell 2012; 149:22–35.

van Riggelen J, Yetil A, Felsher DW . MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer 2010; 10:301–309.

Lin CY, Loven J, Rahl PB, et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 2012; 151:56–67.

Nie Z, Hu G, Wei G, et al. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 2012; 151:68–79.

Dang CV . Gene regulation: fine-tuned amplification in cells. Nature 2014; 511:417–418.

Sabo A, Kress TR, Pelizzola M, et al. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis. Nature 2014; 511:488–492.

Walz S, Lorenzin F, Morton J, et al. Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles. Nature 2014; 511:483–487.

Dang CV . Glutaminolysis: Supplying carbon or nitrogen, or both for cancer cells? Cell Cycle 2010; 9:3884–3886.

Gao P, Tchernyshyov I, Chang TC, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458:762–765.

Kim Jw, Zeller KI, Wang Y, et al. Evaluation of Myc E-Box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays. Mol Cell Biol 2004; 24:5923–5936.

Liu YC, Li F, Handler J, et al. Global regulation of nucleotide biosynthetic genes by c-Myc. PLoS One 2008; 3:e2722.

Dang CV . MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb Perspect Med 2013; 3:a014217–a014217.

Fan J, Ye J, Kamphorst JJ, Shlomi T, Thompson CB, Rabinowitz JD . Quantitative flux analysis reveals folate-dependent NADPH production. Nature 2014; 510:298–302.

Valencia T, Kim JY, Abu-Baker S, et al. Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. Cancer Cell 2014; 26:121–135.

Du W, Jiang P, Mancuso A, et al. TAp73 enhances the pentose phosphate pathway and supports cell proliferation. Nat Cell Biol 2013; 15:991–1000.

Possemato R, Marks KM, Shaul YD, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011; 476:346–350.

Locasale JW, Grassian AR, Melman T, et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 2011; 43:869–874.

Zhang H, Gao P, Fukuda R, et al. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of c-MYC activity. Cancer Cell 2007; 11:407–420.

Xie C, Wu J, Yun J, et al. MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. PLoS One 2013; 8:e64235.

Xie C, Song LB, Wu JH, et al. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a. PLoS One 2012; 7:e40607.